SAP30 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.625800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.604600E-01
Normal-vs-Stage2
8.702000E-01
Normal-vs-Stage3
1.551590E-01
Normal-vs-Stage4
6.024400E-01
Stage1-vs-Stage2
9.249600E-02
Stage1-vs-Stage3
4.059000E-01
Stage1-vs-Stage4
7.154000E-02
Stage2-vs-Stage3
4.513800E-02
Stage2-vs-Stage4
5.401400E-01
Stage3-vs-Stage4
5.497500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.235800E-01
Normal-vs-AfricanAmerican
9.736000E-01
Normal-vs-Asian
3.863600E-01
Caucasian-vs-AfricanAmerican
9.514000E-01
Caucasian-vs-Asian
1.380980E-01
AfricanAmerican-vs-Asian
4.881200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.391400E-01
Normal-vs-Female
9.868600E-01
Male-vs-Female
7.948800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.747800E-01
Normal-vs-Age(41-60Yrs)
6.209800E-01
Normal-vs-Age(61-80Yrs)
8.746400E-01
Normal-vs-Age(81-100Yrs)
8.996400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.023400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.624800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.068600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.558290E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.410400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.755000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.701200E-01
Normal-vs-Daily Drinker
8.996600E-01
Normal-vs-Weekly Drinker
7.880200E-01
Normal-vs-Occasional Drinker
8.781200E-01
Normal-vs-Social Drinker
7.742800E-01
Non Drinker-vs-Daily Drinker
2.514000E-01
Non Drinker-vs-Weekly Drinker
1.509830E-01
Non Drinker-vs-Occasional Drinker
1.046230E-01
Non Drinker-vs-Social Drinker
5.466400E-02
Daily Drinker-vs-Weekly Drinker
4.390600E-01
Daily Drinker-vs-Occasional Drinker
5.844600E-01
Daily Drinker-vs-Social Drinker
4.496800E-01
Weekly Drinker-vs-Occasional Drinker
7.884600E-01
Weekly Drinker-vs-Social Drinker
8.811000E-01
Occasional Drinker-vs-Social Drinker
8.785400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.051200E-01
Normal-vs-Grade 2
9.715200E-01
Normal-vs-Grade 3
9.228600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.895530E-03
Grade 1-vs-Grade 3
3.461700E-02
Grade 1-vs-Grade 4
8.051200E-01
Grade 2-vs-Grade 3
3.055800E-01
Grade 2-vs-Grade 4
9.715200E-01
Grade 3-vs-Grade 4
9.228600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.396600E-01
Normal-vs-NonDiabetic
9.845800E-01
Diabetic-vs-NonDiabetic
8.514000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.364600E-01
Normal-vs-NoPancreatitis
9.557600E-01
Pancreatitis-vs-NoPancreatitis
8.087800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.854000E-01
Normal-vs-N1
8.535800E-01
N0-vs-N1
1.002600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.405000E-01
Normal-vs-TP53-NonMutant
9.786600E-01
TP53-Mutant-vs-TP53-NonMutant
8.969800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
